In situations where the amount of glycosylation is altered and calpains overactivated, such as neurodegenerative diseases or diabetes, calpain cleavage of Reg-1α would generate two new entities: i.e., a peptide of only four amino acids, and the Reg-1αΔN1−4 fragment. The gene discussed is REG1A; the disease is neurodegenerative disease.